ArticleScientific reports2020

High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme.

Thomas J Esparza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.